LNA and α-L-LNA: Towards Therapeutic Applications

Jesper Wengel, Birte Vester, L. Lundberg, Stephen Douthwaite, Mads D. Sørensen, B. Ravindra Babu, Michael J. Gait, Andrey Arzumanov, Michael Petersen, Jakob T. Nielsen

Nucleosides Nucleotides & Nucleic Acids · 2003 · 25 citations · 3 references

Concepts

Abstract

LNA and alpha-L-LNA are promising candidates for the development of efficient oligonucleotide-based therapeutic agents. Here, we report dose-dependent inhibition of HIV-1 Tat-dependent trans activation by a 12-mer chimeric alpha-L-LNA/DNA oligomer. This oligomer exhibits a dose-dependency similar to that of the corresponding 12-mer chimeric LNA/2'-O-Me-RNA oligomer. In addition, we show that incorporation of alpha-L-LNA or LNA monomers into each of the two binding arms of a "10-23" DNAzyme markedly increases cleavage of the target RNA.

References

3